The purpose of this study was to assess the potential of a novel pseudovirus targeting to dendritic cells (DCs) inducing T cells tolerance. To prove it, allogeneic DCs transfected of the novel pseudovirus containing Lewis X oligosaccharides with programmed death-ligand 1 were co-cultured with T cells. After mixed leukocyte reactions were performed, the proliferation, cytokines secretion, and activation marker expression of T cells were analyzed. The results demonstrated that the proliferation, cytokines secretion, and activation marker expression of T cells were suppressed after co-cultured with the pseudovirus transfected DCs. These findings suggested that DCs transfected with pseudovirus could induce T-cells tolerance, which provided a promising therapeutic means to negatively manipulate immune response in organ transplantation.
N umerous evidences demonstrated that T cells played a crucial role in the pathogenesis of immune disorder diseases such as autoimmune disease or organ transplantation, thus inducing tolerance of T cells is regarded as a promising therapeutic means to negatively manipulate immune response (1) (2) (3) (4) . Activation of T cells requires specific signaling by the interaction between the T-cell receptor and Ag presented by antigen-presenting cell, (APCs) and is also regulated by positive and negative co-stimulatory signals (5, 6) . Programmed death-ligand 1 (PD-1) expressed on T cells is an important inhibitory molecule, which binds to the APC ligands PD-L1. On T-cell activation, up-regulation of PD-1 expression also contributes to T-cell homeostasis (7) (8) (9) (10) . Therefore, the negative co-stimulatory pathway PD-1/PD-L1 suppresses T-cell-mediated alloimmunity and induces transplantation tolerance (11) (12) (13) .
Dendritic cells (DCs) are the most potent APCs responsible for priming of naive T cells in initiation of the immune response. Recent studies revealed that DCs were also involved in the maintenance of immunologic self-tolerance (14 -16) . In vivo transfer of Ag-loaded DCs with a tolerogenic character is regarded as a promising therapeutic means to negatively manipulate immune response (17) (18) (19) (20) . In addition, recent investigation also demonstrated that Lewis X oligosaccharides could target to DC-specific intercellular-adhesionmolecule-grabbing nonintegrin, a C-type lectin-like receptor which was mostly expressed on immature DCs (21) (22) (23) (24) . Consequently, this study suggested that the DC-specific intercellularadhesion-molecule-grabbing nonintegrin targeting mediated by Lewis X oligosaccharides could be a novel DC-targeting strategy.
Therefore, according to these findings, we designed a novel pseudovirus, a viron-size particulate which consisted of conjugates of a cell-penetrating peptide of Tat 49 -57 and Lewis X oligosaccharides, and a plasmid encoding human PD-L1. We expected that DCs transfected with pseudovirus could induce T-cells tolerance.
In this study, the 9-mer cationic peptide RKKRRQRRR (Tat 49 -57 ) was synthesized and purified. And, the Lex-TAT compounds were prepared according to the manufacturer's directions. The plasmid PD-L1 and the control plasmid were conserved in our laboratory. Construction and identification of pseudovirus were described previously (25) . In addition, human peripheral blood mononuclear cells were obtained from the whole blood from normal donors over Lymphoprep. Monocytes were purified from peripheral blood mononuclear cells by adherence for 90 min in complete medium. The remaining adherent cells (Ͼ90% monocytes identified by flow cytometry) were induced using 800 U/mL recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF, R&D Systems) and 1000 U/mL interleukin-4 (R&D Systems) for 5 days. DCs were transfected with the pseudovirus, and single-cell suspension was treated with mitomycin C (50 g/mL; Sigma-Aldrich) for 20 min at room temperature and then washed twice with Roswell Park Memorial Institute (culture medium) 1640 as stimulator cells. Allogeneic responder T cells were harvested by negative isolation using magnetic beads, according to the manufacturer's protocol (Dynal T-Cell Negative Isolation kit; Invitrogen Life Technologies). The purity of the CD3ϩ T cells was measured by fluorescence-activated cell sorter (BD Biosciences), and T cells with more than 96% purity were used in this study. Responder (2ϫ10 5 ) and stimulator (4ϫ10 5 ) cells were added to round-bottom 96-well plates to a final volume of 200 L of Roswell Park Memorial Institute (culture medium) 1640 with 10% fetal calf serum.
To investigate whether transfected allogeneic DCs could inhibit proliferation of T cells, [ 3 H] thymidine (0.5 Ci/well) was added 24 hr before harvesting. We observed the proliferation of T cells after 3 days of the one-way mixed leukocyte reaction (MLR) assay. As shown in Figure  1 , the proliferation of T cells in the DC-PD-L1 group was less significant compared with that of DC-P group and DC-phosphate-buffered saline (PBS) group. These results indicated that T-cells proliferative responses were markedly attenuated by pseudovirus-PD-L1 transfected allogeneic DCs.
To further assess whether transfected allogeneic DCs could inhibit cytokine release of T cells, the supernatant was harvested to detect the cytokine release of T cells by ELISA assay after 3 days of the one-way MLR assay. As shown in Figure 2 , after co-cultured with transfected allogeneic DCs, the cytokine release of interleukin-2 and interferon-␥ in the DC-PD-L1 group were lower (59.7Ϯ8.3 and 53.3Ϯ7.6 pg/ mL) compared with that of DC-P group (113.2Ϯ15.1 and 107.6Ϯ14.2 pg/mL) and DC-PBS group (117.8Ϯ15.3 and 110.5Ϯ13.8 pg/mL). The results suggested that pseudovirus-PD-L1 transfected allogeneic DCs could inhibit cytokine release of T cells.
In addition, the activation markers of T cells were also be detected by flow cytometry assay. After 3 days of the one-way MLR assay, the cells were stained with anti-CD3-PE, anti-CD25-fluorescein isothiocyanate, and anti-CD69-APC at 4°C for 1 hr. After washing with PBS, cells were measured using an FCM Calibur flow cytometer and were analyzed with CellQuest software. As shown in Figure 3 , after co-cultured with transfected allogeneic DCs, the activation markers expression of CD25 and CD69 on T cells in the DC-PD-L1 group were lower (7.2%Ϯ1.8% and 17.4%Ϯ3.4%) compared with that of DC-P group (13.5%Ϯ3.1% and 23.8%Ϯ4.2%) and DC-PBS group (14.3%Ϯ3.5% and 27.7%Ϯ5.2%). The results suggested that pseudovirus-PD-L1 transfected allogeneic DCs could suppress the activation markers expression of T cells.
Therefore, our findings may have significant implications for the selection of pseudovirus as an ideal candidate for inducing T-cell tolerance. Future studies will be investigated whether pseudovirus could become a promising strategy for the therapy of organ transplantation in human.
